10 Feb 2022 , 08:13 AM
Net profit of Aurobindo Pharma declined 79.49% to Rs 604.73 crore in the quarter ended December 2021 as against Rs 2948.06 crore during the previous quarter ended December 2020. Sales declined 5.72% to Rs 5989.43 crore in the quarter ended December 2021 as against Rs 6353.13 crore during the previous quarter ended December 2020.
| Particulars | Quarter Ended | ||
| ? | Dec. 2021 | Dec. 2020 | % Var. |
| Sales | 5989.43 | 6353.13 | -6 |
| OPM % | 16.85 | 21.31 | – |
| PBDT | 1058.04 | 1468.03 | -28 |
| PBT | 758.99 | 1191.51 | -36 |
| NP | 604.73 | 2948.06 | -79 |
Powered by Capital Market – Live News
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
